Psoriasis in children: A guide to its diagnosis and management

被引：25
作者：
Leman J. [1 ]
Burden D. [1 ]
机构：
[1] Department of Dermatology, Western Infirmary, Glasgow G11 6NT, Dumbarton Road
来源：
Paediatric Drugs | 2001年 / 3卷 / 9期
关键词：
Psoriasis; Topical Corticosteroid; Calcipotriol; Acitretin; Tazarotene;
D O I：
10.2165/00128072-200103090-00005
中图分类号：
学科分类号：
摘要：
Psoriasis often presents in childhood. The diagnosis may be challenging if the disease is mild or the presentation is atypical. All of the forms recognised in adults are encountered in childhood (plaque, guttate, erythrodermic and pustular). Guttate and flexural forms are particularly common in children. Successful management requires education of the child and parents regarding the course of the disease and treatment options. Environmental triggers should be sought out and eliminated where possible. Most patients respond to topical treatment with emollients, coal tar, anthralin (dithranol) or calcipotriol. Treatment is tailored according to patient age, extent and distribution of psoriasis. For those who fail to respond, daycare or inpatient care is appropriate. Phototherapy with UVB may be combined with topical agents. Systemic therapy is required in a minority, usually those with resistant or erythrodermic disease, pustular psoriasis and arthropathic psoriasis. Retinoids are probably the systemic agent of choice. There are few data regarding the use of methotrexate or cyclosporin in childhood psoriais.
引用
收藏
页码：673 / 680
页数：7
相关论文
共 55 条
  • [31] Mortensen L., Kragballe K., Wegman E., Et al., Treatment of psoriasis vulgaris with topical calcipotriol has no short-term effect on calcium and bone metabolism, Acta Derm Venereol, 73, pp. 300-304, (1993)
  • [32] Darley C.R., Cunliffe W.J., Green C.M., Et al., Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris, Br J Derm, 135, pp. 390-393, (1996)
  • [33] Oranje A.P., Marcoux D., Svensson A., Et al., Topical calcipotriol in childhood posriasis, J Am Acad Dermatol, 36, pp. 203-208, (1997)
  • [34] Park S.B., Suh D.H., Youn J.I., A pilot study to assess the safety and efficacy of topical calcipotriol treatment in childhood psoriasis, Pediatr Dermatol, 16, pp. 321-325, (1999)
  • [35] Krueger G.G., Drake L.A., Elias P.M., Et al., The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis, Arch Dermatol, 134, pp. 57-60, (1998)
  • [36] Esterly N.B., Phototherapy for children, Pediatr Dermatol, 13, pp. 415-426, (1996)
  • [37] Verbov J., Psoriasis in childhood, Arch Dis Child, 67, pp. 75-76, (1992)
  • [38] Van Weelden H., De La Faille H.B., Young E., Et al., Comparison of narrow hand UVB therapy and PUVA photochemothempy in the treatment of psoriasis, Acta Derm Venereol (Stockh), 70, pp. 212-215, (1990)
  • [39] Van Weelden H., De La Faille H.B., Young E., A new development in UVB phototherapy of psoriasis, Br J Dermatol, 119, pp. 11-19, (1988)
  • [40] Green C., Ferguson J., Lakshmiathis T., Et al., 311 nm UVB phototherapy: An effective treatment for psoriasis, Br J Dermatol, 119, pp. 691-696, (1988)
123456